An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996–2023
Aktualisierte systematische Übersicht und Metaanalyse zur Prävalenz von Typ-2-Diabetes im Iran, 1996–2023
Frontiers in Public Health · 04.04.2024 · 12
DOI: 10.3389/fpubh.2024.1322072 ↗Auf einen Blick
53 Studien zeigen eine geschätzte Prävalenz von Typ-2-Diabetes im Iran von 10,8 %. Die Prävalenz war bei Frauen, in der Altersgruppe 55–64 Jahre und regional unterschiedlich höher.
Fragestellung
Wie hoch sind Prävalenz und zeitliche Trends von Diabetes mellitus Typ 2 im Iran von 1996 bis 2023?
Methode
Systematische Übersicht und Metaanalyse; Suche bis Juli 2023 in persischen und englischen Datenbanken; Qualität mit JBI-Checkliste bewertet, Analyse mit random-effects-Modell, Subgruppenanalyse, Meta-Regression, Sensitivitätsanalyse und kumulativer Metaanalyse.
Ergebnisse
53 Studien mit 1.244.896 Personen. Prävalenz: Männer 10,80 % (95 %-KI 9,1–12,4), Frauen 13,4 % (95 %-KI 11,6–15,3), 55–64 Jahre 21,7 % (95 %-KI 17,5–25,0).
Schlussfolgerung der Autor:innen
Die Prävalenz von Typ-2-Diabetes wurde auf 10,8 % geschätzt; Unterschiede nach Geschlecht, Alter und Region sprechen für spezifische Interventionen.
Kernaussagen
- Prävalenz insgesamt: 10,8 %
- Höhere Prävalenz bei Frauen und in der Altersgruppe 55–64 Jahre
- Zeitlicher Anstieg besonders von 2013 bis 2017
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift Frontiers in Public Health, online erschienen am 04.04.2024. Verfasst von Narjes Hazar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes mellitus (DM) poses a significant threat to public health, and the anticipated surge of over 100% in the age-standardized prevalence of type 2 diabetes in Iran between 2021 and 2050 underscores the pressing need for focused attention. The rationale for estimating the prevalence of type 2 diabetes in Iran becomes even more compelling when considering the potential cascading effects on the healthcare system, quality of life, and economic burden. The aim of this study was to estimate the prevalence and trends of DM from 1996 to 2023 in the Islamic Republic of Iran.
Methods
Up to July 2023, without deadlines, the search for appropriate articles in Persian and English. Iranian sources including SID, Magiran, and Element were included in the databases, along with foreign ones like PubMed/MEDLINE, Web of Science, Science Direct, Embase, Scopus, ProQuest, and Google Scholar. Using the JBI quality checklist, the study’s level of quality was evaluated. Version 14 of STATA was used to carry out the statistical analysis. The Dersimonian and Liard random-effects models were used because of heterogeneity. To investigate the causes of heterogeneity, subgroup analysis and univariate meta-regression were utilized. Sensitivity analysis was then carried out to see how each study’s findings affected the final findings. The prevalence pattern over time was also followed using cumulative meta-analysis.
Results
There were 53 studies in all, with a combined sample size of 1,244,896 people. Men were predicted to have a type 2 diabetes prevalence of 10.80% (95% CI: 9.1–12.4), while women were assessed to have a prevalence of 13.4% (95% CI: 11.6–15.3). Additionally, the prevalence of diabetes was much higher in the 55–64 age group, coming in at 21.7% (95% CI: 17.5–25.0). The anticipated prevalence of diabetes was 7.08% for 1988 to 2002, 9.05% for 2003 to 2007, 9.14% for 2008 to 2012, 15.0% for 2013 to 2017, and 13.40% for 2018 to 2023, among other time periods. Geographically, type 2 diabetes was most prevalent in Khuzestan (15.3%), followed by Razavi Khorasan (14.4%), Qazvin (14.3%), and Yazd (12.6%).
Conclusion
The prevalence of type 2 diabetes was estimated at 10.8%, highlighting variations across gender, age groups, and geographic regions that underscore the necessity for specific interventions. These findings advocate for proactive measures, including tailored screening and lifestyle modification programs. The notable temporal increase from 2013 to 2017 signals the need for policymakers and healthcare practitioners to develop effective strategies, anticipating and addressing the potential future burden on the healthcare system. Systematic Review Registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023437506 , identifier: CRD42023437506.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Young Researchers and Elite Club, Islamic Azad University of Karaj, Karaj, Iran.
- Research Center for Non Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Fars, Iran.
- Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Public Health, Torbat Jam Faculty of Medical Science, Torbat Jam, Iran.
Zitieren
APA
Hazar, N., Jokar, M., Namavari, N., Hosseini, S., & Rahmanian, V. (2024). An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996–2023. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1322072
Vancouver
Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996–2023. Frontiers in Public Health. 2024;12. doi:10.3389/fpubh.2024.1322072
BibTeX
@article{Hazar2024,
author = {Hazar, Narjes and Jokar, Mohammad and Namavari, Negin and Hosseini, Saeed and Rahmanian, Vahid},
title = {An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996–2023},
journal = {Frontiers in Public Health},
year = {2024},
volume = {12},
doi = {10.3389/fpubh.2024.1322072}
}
EUVIMED